Cargando…
Aberrant Signaling Pathways in T-Cell Acute Lymphoblastic Leukemia
T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive disease caused by the malignant transformation of immature progenitors primed towards T-cell development. Clinically, T-ALL patients present with diffuse infiltration of the bone marrow by immature T-cell blasts high blood cell counts, med...
Autores principales: | Bongiovanni, Deborah, Saccomani, Valentina, Piovan, Erich |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618553/ https://www.ncbi.nlm.nih.gov/pubmed/28872614 http://dx.doi.org/10.3390/ijms18091904 |
Ejemplares similares
-
miR-22-3p Negatively Affects Tumor Progression in T-Cell Acute Lymphoblastic Leukemia
por: Saccomani, Valentina, et al.
Publicado: (2020) -
Calcineurin complex isolated from T-cell acute lymphoblastic leukemia (T-ALL) cells identifies new signaling pathways including mTOR/AKT/S6K whose inhibition synergize with calcineurin inhibition to promote T-ALL cell death
por: Tosello, Valeria, et al.
Publicado: (2016) -
Responsiveness to Hedgehog Pathway Inhibitors in T-Cell Acute Lymphoblastic Leukemia Cells Is Highly Dependent on 5′AMP-Activated Kinase Inactivation
por: Tosello, Valeria, et al.
Publicado: (2021) -
Aberrant splicing in B-cell acute lymphoblastic leukemia
por: Black, Kathryn L, et al.
Publicado: (2018) -
Aberrant splicing in B-cell acute lymphoblastic leukemia
por: Black, Kathryn L, et al.
Publicado: (2019)